Genome instability in multiple myeloma: Facts and factors
Simple Summary Multiple myeloma is an incurable blood cancer caused by the malignant
transformation of immunoglobulin-producing plasma cells. The mechanisms leading to the …
transformation of immunoglobulin-producing plasma cells. The mechanisms leading to the …
[HTML][HTML] Rakesh Gaur, MD, MPH, FACP
G Gaur, J Amos, A Qasem, KC Spengel - mdedge9-ma1.mdedge.com
DISCUSSION KFD presents subacutely with LAD, fever, weight loss, and varying skin
findings, often self-resolving. Diagnosis requires lymph node biopsy. Etiology is unclear …
findings, often self-resolving. Diagnosis requires lymph node biopsy. Etiology is unclear …
[PDF][PDF] Combination of Ibrutinib and Rituximab Prolongs Progression-Free Survival in Waldenström Macroglobulinemia
MA Dimopoulos, A Tedeschi, J Trotman - JCOM, 2018 - cdn.mdedge.com
Main outcome measures. The primary outcome of this study was progression-free survival
(PFS). Secondary endpoints included time to next treatment, overall survival (OS), response …
(PFS). Secondary endpoints included time to next treatment, overall survival (OS), response …
[HTML][HTML] Prescription Drug Benefits and Survival in Myeloma Among Medicare Beneficiaries
R Gaur - Journal of Clinical Outcomes Management, 2018 - mdedge9-ma1.mdedge.com
Prescription Drug Benefits and Survival in Myeloma Among Medicare Beneficiaries | Journal of
Clinical Outcomes Management Skip to main content Home Journal of Clinical Outcomes …
Clinical Outcomes Management Skip to main content Home Journal of Clinical Outcomes …